Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

MRK Merck and Co Inc

100,87

1,62 (1,63%)

Zuletzt aktualisiert: 21:20:06

Verzögert um 15 Minuten

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

null

Merck (NYSE:MRK)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Merck Charts.

Merck (NYSE:MRK)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Merck Charts.

News Merck and Co Inc

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments
Montag 13 Januar 2025 (7 Stunden vor) • AllPennyStocks.com

Merck’s GARDASIL® Receives Expanded Approval for Males in China
Mittwoch 8 Januar 2025 (5 Tage vor) • Business Wire

Merck to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Montag 6 Januar 2025 (1 Woche vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Montag 23 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Merck Closes Exclusive Global License Agreement for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody
Freitag 20 Dezember 2024 (3 Wochen vor) • Business Wire

Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults with Virologically Suppressed HIV-1 Infection
Donnerstag 19 Dezember 2024 (4 Wochen vor) • Business Wire

Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist
Mittwoch 18 Dezember 2024 (4 Wochen vor) • Business Wire

Weitere Merck and Co Inc News-Artikel

Deutsche Lufthansa

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen